Product Program year 2025 Source: CMS Open Payments

Skysona

Drug Gene Therapy

NDC 73554-2111-1

Open in the dashboard

General payments

$20,380

9 payments

Research payments

$0

0 payments

Through program year 2025, $20,380 in general payments and $0 in research payments were reported against Skysona (Gene Therapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $20,380 9

Breakdown

Who paid General payments · program year 2025
  1. bluebird bio, Inc. $20,380 9 payments
Top recipients General payments · program year 2025
  1. Massachusetts General Hospital Teaching hospital · MA $10,000 49% · 1 payment
  2. Daniel Loes Diagnostic Radiology · Roseville, MN $7,848 39% · 5 payments
  3. Abdullah Kutlar Hematology & Oncology · Augusta, GA $1,020 5% · 1 payment
  4. Morton Cowan Pediatric Allergy/Immunology · San Francisco, CA $825 4% · 1 payment
  5. Richard Champlin Hematology & Oncology · Houston, TX $688 3% · 1 payment

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Diagnostic Radiology Radiology $7,848 76% · 1 practitioner
  2. Hematology & Oncology Internal Medicine $1,708 16% · 2 practitioners
  3. Pediatric Allergy/Immunology Pediatrics $825 8% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Massachusetts $10,000 49% · 1 recipient
  2. Minnesota $7,848 39% · 1 recipient
  3. Georgia $1,020 5% · 1 recipient
  4. California $825 4% · 1 recipient
  5. Texas $688 3% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

9 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record